PF-00610355 Uses, Dosage, Side Effects and more
PF-00610355 has been used in trials studying the treatment of Lung Disease, Moxifloxacin, Pulmonary Disease, Asthma, Bronchial, and Bronchial Diseases, among others.
| Attribute | Details |
|---|---|
| Trade Name | PF-00610355 |
| Generic | PF-00610355 |
| Type | |
| Formula | C34H39N3O6S |
| Weight | Average: 617.76 Monoisotopic: 617.255957162 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
